Coherus BioSciences Inc (NASDAQ:CHRS)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - CHRS
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - CHRS
- Market Cap$1.321bn
- SymbolNASDAQ:CHRS
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS19249H1032
Company Profile
Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.Coherus BioSciences Inc is a biotechnology company that develops biosimilar therapeutics. The company seeks to ensure successful drug development and manufacturing under very aggressive timelines.
Latest CHRS news
Currently there for this company. Visit our news hub for other news .